Status:
ACTIVE_NOT_RECRUITING
Sleep Disordered Breathing (SDB) Prevalence and Cardiovascular Outcomes of Myocardial Infarction (MI) Survivors
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
National Research Agency, France
Conditions:
Acute Myocardial Infarction
Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The AMISLEEP study is nested in the "FRENCHIE" registry. The objective is to use routine clinical and polygraphic data to capture SDB/SAS (Sleep Disordered Breathing/Sleep Apnea Syndrome) physiologic...
Detailed Description
All patients included in the "FRENCHIE" registry (Acute Myocardial Infarction (AMI) patients hospitalized within 48h from symptom onset) are eligible, and will be asked for their written informed cons...
Eligibility Criteria
Inclusion
- Patient included in FRENCHIE registry (cf. NCT04050956 for FRENCHIE registry's selection criteria)
- Signed consent for AMI-Sleep study
Exclusion
- Patient under treatment for SDB/SAS prior to its inclusion in FRENCHIE registry
- Cognitive disorientation and communicative disabilities (left to investigator's discretion) not able to fill-out a questionnaire
- Severe diseases with anticipated mortality less than 6 months
Key Trial Info
Start Date :
April 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
2007 Patients enrolled
Trial Details
Trial ID
NCT04064593
Start Date
April 11 2019
End Date
September 1 2024
Last Update
February 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Bichat, AP-HP
Paris, France